Breaking News Instant updates and real-time market news.

FOMX

Foamix

$3.15

-0.09 (-2.78%)

14:46
10/18/19
10/18
14:46
10/18/19
14:46

Foamix trading halted, news pending

  • 18

    Oct

  • 20

    Oct

FOMX Foamix
$3.15

-0.09 (-2.78%)

12/12/18
12/12/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Foamix (FOMX) initiated with a Buy at BofA/Merrill. 2. Jazz Pharmaceuticals (JAZZ) initiated with an Outperform at Oppenheimer while GW Pharmaceuticals (GWPH) was initiated with a Perform. 3. Six Flags (SIX) initiated with a Buy at Berenberg. 4. iQIYI (IQ) initiated with a Hold at HSBC. 5. Intercept (ICPT), Viking Therapeutics (VKTX), and Galmed (GLMD) were initiated with a Buy at B. Riley FBR, while Madrigal Pharmaceuticals (MDGL) initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/11/19
LEHM
06/11/19
INITIATION
Target $10
LEHM
Overweight
Foamix initiated with an Overweight at Barclays
Barclays analyst Balaji Prasad started Foamix Pharmaceuticals with an Overweight rating and $10 price target. The analyst launched coverage of 20 U.S. Specialty Pharmaceuticals with a Neutral industry view. He placed importance on cash flows and companies' ability to manage leverage and improve balance sheets.
10/08/19
CANT
10/08/19
NO CHANGE
Target $15
CANT
Overweight
Cantor reiterates Overweight on Foamix ahead of FMX101 PDUFA
Cantor Fitzgerald analyst Louise Chen says her 25 physician survey supports her positive view on the market opportunity for Foamix's FMX10. If approved, FMX101 has the potential to address a significant unmet need in the treatment of moderate-to-severe acne, which remains a difficult condition, Chen tells investors in a research note. She reiterates an Overweight rating on Foamix shares with a $15 price target ahead of the upcoming FDA action date for FMX101 on October 20. The analyst thinks the Street is underestimating the uptake of acne drugs.
10/16/19
LEHM
10/16/19
NO CHANGE
Target $10
LEHM
Overweight
Barclays likes Foamix setup into October 20 FDA action date
Barclays analyst Balaji Prasad highlights Foamix Pharmaceuticals' key upcoming FDA action date of October 20 for FMX-101 in acne. The analyst says ~75% of his $10 price target is derived from FMX-101, and that approval could add another $2, or 320% potential upside from current share levels. The analyst sees a 90% probability of success and forecasts 2025 risk adjusted sales of $202M. Prasad continues to like Foamix's risk/reward setup going into the October 20 PDUFA and he reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

AFL

Aflac

$53.29

0.22 (0.41%)

14:51
12/10/19
12/10
14:51
12/10/19
14:51
Hot Stocks
Aflac VP Steven Beaver sells over $300K in company shares »

Aflac VP Steven Beaver…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 05

    Feb

  • 26

    Feb

GME

GameStop

$6.44

0.12 (1.90%)

14:49
12/10/19
12/10
14:49
12/10/19
14:49
Options
GameStop options imply 26.8% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 13

    Dec

AM

Antero Midstream

$5.47

0.335 (6.52%)

14:45
12/10/19
12/10
14:45
12/10/19
14:45
Options
Antero Midstream call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$72.94

-2.05 (-2.73%)

, CI

Cigna

$190.12

-5.77 (-2.95%)

14:44
12/10/19
12/10
14:44
12/10/19
14:44
Hot Stocks
CVS, Cigna fall after Blue Cross Blue Shield's PillPack announcement »

Shares of CVS Health…

CVS

CVS Health

$72.94

-2.05 (-2.73%)

CI

Cigna

$190.12

-5.77 (-2.95%)

AMZN

Amazon.com

$1,740.40

-9.21 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

MDP

Meredith

$35.35

-0.54 (-1.50%)

14:41
12/10/19
12/10
14:41
12/10/19
14:41
Conference/Events
Meredith management to meet with Benchmark »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

EBAY

eBay

$34.85

0.275 (0.80%)

14:30
12/10/19
12/10
14:30
12/10/19
14:30
Hot Stocks
eBay Canada's Stairs says CUSMA pact a 'win for Canadian small businesses' »

"The new CUSMA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$314.12

0.25 (0.08%)

, SPX

S&P 500

$0.00

(0.00%)

14:30
12/10/19
12/10
14:30
12/10/19
14:30
Periodicals
Breaking Periodicals news story on SPDR S&P 500 ETF Trust, S&P 500 »

McConnell says Senate…

SPY

SPDR S&P 500 ETF Trust

$314.12

0.25 (0.08%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$34.60

0.76 (2.25%)

14:27
12/10/19
12/10
14:27
12/10/19
14:27
Recommendations
MorphoSys analyst commentary  »

MorphoSys sounds close to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AEP

American Electric

$91.94

0.045 (0.05%)

14:23
12/10/19
12/10
14:23
12/10/19
14:23
Hot Stocks
PSO reaches settlement pact with Public Utility Division Staff of OCC »

Public Service Company of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

CORV

Correvio

$1.39

(0.00%)

14:22
12/10/19
12/10
14:22
12/10/19
14:22
Periodicals
FDA panel said to vote against recommending approval for Correvio's Brinavess »

SAC Tracker, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Dec

14:20
12/10/19
12/10
14:20
12/10/19
14:20
General news
The Europe Brief: »

The Europe Brief:…

EVH

Evolent Health

$9.02

1.125 (14.25%)

14:17
12/10/19
12/10
14:17
12/10/19
14:17
Recommendations
Evolent Health analyst commentary  »

William Blair says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/10/19
12/10
14:17
12/10/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/10/19
12/10
14:16
12/10/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONN

Conn's

$14.09

-6.42 (-31.30%)

14:03
12/10/19
12/10
14:03
12/10/19
14:03
Downgrade
Conn's rating change  »

Conn's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

CONN

Conn's

$14.08

-6.43 (-31.35%)

13:59
12/10/19
12/10
13:59
12/10/19
13:59
Downgrade
Conn's rating change  »

Conn's downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

EVH

Evolent Health

$8.46

0.565 (7.16%)

13:59
12/10/19
12/10
13:59
12/10/19
13:59
Periodicals
Kentucky committee rejects outgoing governor's 'snub' of Evolent, LBF says »

The Government Contract…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UDR

UDR, Inc.

$47.78

-0.11 (-0.23%)

13:56
12/10/19
12/10
13:56
12/10/19
13:56
Conference/Events
UDR, Inc. management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

XOM

Exxon Mobil

$68.73

-0.93 (-1.34%)

13:54
12/10/19
12/10
13:54
12/10/19
13:54
Hot Stocks
Exxon: Ruling affirms position company has held throughout 'baseless' probe »

ExxonMobil issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ADPT

Adaptive Biotechnologies

$29.09

-0.21 (-0.72%)

13:54
12/10/19
12/10
13:54
12/10/19
13:54
Conference/Events
Adaptive Biotechnologies management to meet with JPMorgan »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVGO

Livongo Health

$25.83

-1.57 (-5.73%)

13:52
12/10/19
12/10
13:52
12/10/19
13:52
Recommendations
Livongo Health analyst commentary  »

Livongo Health valuation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

WDFC

WD-40

$194.62

-1.12 (-0.57%)

13:51
12/10/19
12/10
13:51
12/10/19
13:51
Hot Stocks
WD-40 increases quarterly dividend nearly 10% »

WD-40 Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

13:50
12/10/19
12/10
13:50
12/10/19
13:50
General news
Treasury Action: the Treasury market is unmoved »

Treasury Action: the…

13:49
12/10/19
12/10
13:49
12/10/19
13:49
Conference/Events
JPMorgan consumer finance analyst to hold analyst/industry conference call »

Specialty & Consumer…

EVH

Evolent Health

$8.27

0.375 (4.75%)

13:49
12/10/19
12/10
13:49
12/10/19
13:49
Hot Stocks
Evolent Health jumps $1.55, or 20%, to $9.42 »

Contacts tell The Fly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.